- Quotes
- Dashboard
- Chart
- Historical Prices
- Options
- News & PR
- News
- Market Currents
- Press Releases
- Coverage
- Cramer
- Top Analysts
- Business Intelligence
- Transcripts
- Events
- Key Developments
- Earnings
- History & Projected
- Consensus
- Peer Earnings
- Filings
- SEC Filings
- Annual Report
- Financials
- Income Statement
- Balance Sheet
- Cash Flow
52wk high:
52wk low:
EPS:
PE:
Div Rate:
Yield:
Market Cap:
Volume:
LCI Market Currents
more »
-
January 30 Shares of Lannett Company (LCI) gain 3.6% premarket after the company lands FDA approval for its Hydrochlorothiazide capsules used to treat high blood pressure.
Comment![On the Move, Healthcare]
LCI in Focus
more »
LCI Related Articles
more »
LCI News
more »
Currently, there are no news on LCI.
LCI Press Releases and Filings
more »
-
Business Wire (May 11, 2012)
-
Business Wire (May 8, 2012)
-
Business Wire (May 2, 2012)
-
Business Wire (Jan 6, 2012)
-
Business Wire (Jan 4, 2012)
LCI Latest Transcript
more »
Currently, there are no transcripts for LCI.
LCI Cramer
more »
Currently, there are no Cramer articles on LCI.
LCI Instablog posts
more »
LCI vs. ETF Alternatives
Company Description
Currently, there's no company description for LCI.